Shanghai Kehua Bio-engineering Co Ltd - Company Profile
Powered by
All the data and insights you need on Shanghai Kehua Bio-engineering Co Ltd in one report.
- Save hours of research time and resources with
our up-to-date Shanghai Kehua Bio-engineering Co Ltd Strategy Report
- Understand Shanghai Kehua Bio-engineering Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Shanghai Kehua Bio-engineering Co Ltd (KHB) is a medical device company that develops, manufactures and markets in vitro diagnostic devices and related products. The company’s product portfolio includes COVID-19 products, immunologic diagnosis, biochemical diagnosis, molecular diagnosis and POCT (point-of-care testing) products. It also offers comprehensive services for regional medical communities. KHB established R&D centers and production bases in many countries and regions including Italy. The company has sales support facilities in major cities in China and markets products in China and other countries through distributors. It is also a global supplier of IVD products to WHO, UNICEF, PEPFAR, and Clinton HIV/AIDS Initiative. KHB is headquartered in Shanghai, China.
Shanghai Kehua Bio-engineering Co Ltd premium industry data and analytics
Products and Services
Products | Brands |
---|---|
- | KHB |
Diagnostic Kit for SARS-CoV-2 IgM/IgG Antibody (Colloidal Gold) | |
Diagnostic Kit for SARS-CoV-2 Nucleic Acid (Real Time PCR) | |
XYZ | |
XYZ | |
XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2023 | Contracts/Agreements | In January, the company entered into an agreement with Xinshao County People's Hospital jointly to build a cooperative demonstration unit and introduce the KHB Polaris LAS automatic biochemical immune assembly line. |
2023 | Contracts/Agreements | In December, Kehua Biotech and the Department of Infectious Diseases of Jiangxi Provincial People's Hospital joined forces to launch free-of-charge treatment for a standardized diagnosis and to cure hepatitis patients. |
2022 | Contracts/Agreements | In November, Kehua Biologics and Shanghai MCC Hospital entered into a clinical translation research center cooperation agreement to improve scientific research capabilities to strengthen the construction of innovative talent teams. |
Competitor Comparison
Key Parameters | Shanghai Kehua Bio-engineering Co Ltd | Shenzhen Mindray Bio-Medical Electronics Co Ltd | Daan Gene Co Ltd | Edan Instruments Inc | Beijing Strong Biotechnologies Inc |
---|---|---|---|---|---|
Headquarters | China | China | China | China | China |
City | Shanghai | Shenzhen | Guangzhou | Shenzhen | Beijing |
State/Province | Shanghai | Guangdong | Guangdong | Guangdong | Beijing |
No. of Employees | 2,709 | 16,099 | 3,580 | 2,711 | 1,094 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Ma Zhichao | Chairman | Executive Board | - | 43 |
Fang Luo | Chief Financial Officer | Senior Management | - | 51 |
Chao Chen | Senior Vice President; Director | Executive Board | - | 46 |
Li Ming | President | Senior Management | 2023 | 47 |
Wang Xilin | Vice President | Senior Management | - | 53 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward